Application 213796
- Type
- ANDA
- Sponsor
- EDENBRIDGE PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42799-935 | Doxepin Hydrochloride | Doxepin Hydrochloride | Edenbridge Pharmaceuticals LLC. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 71915 | ORIG | 2022-08-26 |